Correlation Between Bristol Myers and Evogene
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Evogene, you can compare the effects of market volatilities on Bristol Myers and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Evogene.
Diversification Opportunities for Bristol Myers and Evogene
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bristol and Evogene is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of Bristol Myers i.e., Bristol Myers and Evogene go up and down completely randomly.
Pair Corralation between Bristol Myers and Evogene
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.4 times more return on investment than Evogene. However, Bristol Myers Squibb is 2.49 times less risky than Evogene. It trades about 0.15 of its potential returns per unit of risk. Evogene is currently generating about -0.21 per unit of risk. If you would invest 4,069 in Bristol Myers Squibb on September 1, 2024 and sell it today you would earn a total of 1,853 from holding Bristol Myers Squibb or generate 45.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Evogene
Performance |
| Timeline |
| Bristol Myers Squibb |
| Evogene |
Bristol Myers and Evogene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Evogene
The main advantage of trading using opposite Bristol Myers and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.| Bristol Myers vs. Crinetics Pharmaceuticals | Bristol Myers vs. Enanta Pharmaceuticals | Bristol Myers vs. Amicus Therapeutics | Bristol Myers vs. Connect Biopharma Holdings |
| Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |